MedTrace Logo

Neural and Antidepressant Effects of Propofol

NCT03684447 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2024-05-07

No results posted yet for this study

Summary

This study will compare the antidepressant effects of propofol at two different doses while measuring potential treatment-related biomarkers.

Conditions

Interventions

DRUG

Propofol

Series of 6 treatments with propofol.

DRUG

Propofol

Series of 6 treatments with propofol. May be able to cross over and receive 6 additional treatments with the high dose of propofol.

Sponsors & Collaborators

Principal Investigators

  • Brian J Mickey, MD, PhD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-21
Primary Completion
2022-12-31
Completion
2024-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03684447 on ClinicalTrials.gov